Specifications Table {#s0005}
====================

TableSubject areaMedicineMore specific subject areaDiagnostic Radiology, X-ray Imaging, Radiation dosimetry, Radiation ProtectionType of dataTables and figuresHow data was acquiredThermoluminescent dosimeters (TLD-100; RadPro, Poland), PCXMC Software (20Rotation), Quality Control Kits (MagicMax, Germany)Data formatRaw, AnalyzedExperimental factorsThe aforementioned parameters in the abstracts were analyzed according to International Atomic Energy Agency (IAEA) standards for radiation protection of patientsExperimental featuresDetermination of entrance surface dose, effective dose and bone marrow dose, breast dose and lung dose in order to estimate the risk of radiation induced cancer from chest radiographyData source locationObafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Osun State, NigeriaData accessibilityAll the data are in this data article

Value of the data {#s0010}
=================

•The data can be used to assess incidence cancer risk from chest radiography in the State.•The data will help to curtail the demand for chest radiography for school admission and employment purposes.•The data will enhance the optimization of radiographic procedures in the State to be as low as reasonably achievable.•The data is useful in radiation protection training and epidemiology studies.•Cancer risks assessment can be extended to other irradiated organs arising from chest radiography not covered in this study.•The study can be extended to multi-centre studies.•The data can be helpful to radiation regulatory authorities and policy makers.

1. Data {#s0015}
=======

The data contains radiation doses and incidence of cancer risks among young adult females who underwent chest radiography for school admission purposes. Radiation protection of patients in diagnostic radiology is a subject of global concern. Concerted effort to minimizing patient׳s dose has led to generation of datasets [@bib1], [@bib2], [@bib3], [@bib4], [@bib5]. Justification of radiographic examinations and optimization of the procedures have been the emphasis for the protection of patients [@bib2], [@bib5], [@bib6]. Data on some experiences leading to the discouragement of requests for chest radiography used for school admission and employment purposes can be found in [@bib7], [@bib8], [@bib9]. Data on the risks of cancer induction from low dose ionizing radiation can be found in [@bib10], [@bib11], [@bib12], [@bib13], [@bib14]. Beyond cancer induction other radiation risks have been reported [@bib15], [@bib16], [@bib17].

1.1. Description of data {#s0020}
------------------------

The patient parameters, technical factors, radiation doses and incidence cancer risks are presented in [Tables 1](#s0065){ref-type="sec"}, [Table 1](#t0005){ref-type="table"}, [Table 6](#t0030){ref-type="table"}. Descriptive analysis of patient parameters and technical factors are presented in [Table 2](#t0005){ref-type="table"} and the descriptive analysis of radiation doses and cancer risks is reported in [Table 7](#t0030){ref-type="table"}. The influence of patient parameters and technical factors on entrance surface dose (ESD) is reported in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"}. [Fig. 1](#f0005){ref-type="fig"} compares the entrance surface dose (ESD) with world data ([Table 7](#t0035){ref-type="table"}). The cancer risks ratio is presented in [Table 7](#t0035){ref-type="table"}.Table 1Descriptive statistics of patient parameters and technical factors.Table 1**AgeBMIFFDFSDkVpmAs***N*Valid404040404040Missing000000Mean20.2522.8815147.23121.5874.1323.50Median20.0022.2700153.00124.0074.0025.00Std. Deviation2.2953.822418.7107.8282.6334.591Variance5.26914.61175.87161.2766.93321.077Skewness0.3600.321− 1.143− 0.2670.1150.510Std. Error of Skewness0.3740.3740.3740.3740.3740.374Kurtosis− 1.016− 0.622− 0.467− 1.311− 0.794− 0.341Std. Error of Kurtosis0.7330.7330.7330.7330.7330.733Range814.842226916Minimum1715.631311097016Maximum2530.471531357932[^1]Table 2Model Summary for entrance surface dose, patient parameters and technical factors.Table 2Model*RR* squareAdjusted *R* squareStd. error of the estimate0.7750.6010.5280.16941Table 3Analysis of variance for entrance surface dose, patient parameters and technical factors.Table 3ModelSum of squaresd*f*Mean square*F*Sig.1Regression1.42560.2378.2750.000Residual0.947330.029Total2.37239Table 4Coefficients of variables.Table 4ModelUnstandardized coefficientsStandardized coefficients*t*Sig.*B*Std. errorBeta1(Constant)1.7392.0330.8550.399Age0.0240.0200.2251.2250.229BMI0.0240.0170.3711.4270.163FFD− 0.0190.006− 0.666− 3.2840.002FSD0.0130.0070.4281.9080.065kVp0.0020.0330.0220.0630.950mAs− 0.0300.012− 0.563− 2.5650.015Table 5Correlation matrix of entrance surface dose, patient parameters and technical factors.Table 5**CorrelationsESDAgeBMIFFDFSDkVpmAsPearsonESD**1**Age**0.5391**BMI**0.2340.5681**FFD**− 0.620− 0.3800.0391**FSD**− 0.1290.1630.4420.6071**kVp**0.3790.7410.859− 0.1290.5021**mAs**− 0.0460.4180.7930.2470.6460.7601**Kendall׳sESD**1**Age**0.4501**BMI**0.2210.3551**FFD**− 0.544− 0.384− 0.0951**FSD**− 0.0110.1900.2700.4091**kVp**0.3680.5960.641− 0.2630.3301**mAs**0.0370.3010.6270.1540.5450.5871**Spearman׳sESD**1**Age**0.6201**BMI**0.3140.4911**FFD**− 0.685− 0.479− 0.0981**FSD**− 0.0500.2420.3950.4821**kVp**0.5060.7530.777− 0.3020.4451**mAs**0.0280.3750.7340.1750.6870.6741[^2]Table 6Descriptive statistics of radiation doses and cancer risks incidence.Table 6**ESDEBMDBDLDICR**~**BM**~**ICR**~**B**~**ICR**~**L**~**ICR**~**S**~*N*Valid404040404040404040Missing000000000Mean1.080.160.180.190.660.780.812.814.56Median1.000.150.170.180.610.730.812.824.35Std. Deviation0.2470.0430.0430.0670.1840.1620.2990.7990.879Variance0.0610.0020.0020.0040.0340.0260.0890.6380.772Skewness0.9591.6281.3341.1741.5581.5590.7991.1691.255Std. Error of Skewness0.3740.3740.3740.3740.3740.3740.3740.3740.374Kurtosis0.1542.7731.0581.9422.6152.6011.3462.3391.405Std. Error of Kurtosis0.7330.7330.7330.7330.7330.7330.7330.7330.733Range1.010.200.180.320.860.751.403.924.01Minimum0.680.110.130.090.430.580.351.613.24Maximum1.690.310.310.411.291.341.755.537.25Percentiles250.890.140.160.140.540.670.542.173.94501.000.150.170.180.610.720.812.824.35751.180.170.200.220.700.850.973.264.93[^3]Table 7Incidence cancer risks ratio for chest radiography.Table 7**ICR**~**BM**~**RatioICR**~**B**~**RatioICR**~**L**~**RatioICR**~**S**~**Ratio**Mean0.781:1000000.811:1000002.813:1000004.565:100000Minimum0.580.351.612:1000003.243:100000Maximum1.341:1000001.752:1000005.536:1000007.257:100000Percentiles250.670.542.172:1000003.944:100000500.730.811:1000002.823:1000004.354:100000750.851:1000000.971:1000003.263:1000004.935:100000***Level of Risk:***1: 1,000,000--1: 100,000: Minimal risk1: 100,000--1: 10,000: very low risk[^4]Fig. 1Comparison of entrance surface dose [@bib3], [@bib18], [@bib19], [@bib20].Fig. 1Fig. 2Scatter line plot for entrance surface dose (ESD), focus to film distance (FFD) and current time product (mAs).Fig. 2

2. Experimental design, materials and methods {#s0025}
=============================================

2.1. Data collection {#s0030}
--------------------

Data was collected during chest radiography of young adult females (aged 17--25 year) at the x-ray unit of Radiology Departments of Obafemi Awolowo University Teaching Hospital Complex Ile-Ife, Osun State, Nigeria. The participants were students admitted into one of the Schools of the University Teaching Hospital for the year 2017. Consent was obtained from each participant before the commencement of the examination. Entrance surface dose (ESD) were determined using thermoluminescent dosimeters (TLD-100: LiF: Mg, Ti) from RadPro International GmbH, Poland. Each of the TLD chip was enclosed in labelled black polythene pack. A total of three coded chips were used to measure the entrance surface dose (ESD) during the procedure in order to obtain the mean and enhance precision. The chips were attached to an elastic tape and placed in the centre of x-rays field where the beam intercepted with the irradiated part of the patient. Patient׳s clinical information and exposure parameters were noted and recorded using self-structured form. The x-ray machine output parameters were determined using MagicMax quality control kits (IBA Dosimetry, Germany).

2.2. Data collection tool {#s0035}
-------------------------

The TLD chips were oven-annealed using Carbolite oven made in England. Irradiation of TLD chips for calibration (for TLD chips and Reader) was conducted at the Secondary Standard Dosimetry Laboratory (SSDL) of the National Institute of Radiation Protection and Research (NIRPR), Ibadan. TLD chips were read using Harshaw Reader (Model 3500) at the Department of Physics, Obafemi Awolowo University Ile-Ife.

2.3. Data analysis {#s0040}
------------------

The bone marrow dose, breast dose, lung dose and effective doses were evaluated from the measured entrance surface dose (ESD) using PCXMC software (version 20Rotation). Thereafter, BEIR VII model software was used to estimate the incidence cancer risk.

2.4. The study centre {#s0045}
---------------------

The hospital is the only federal tertiary healthcare institution in the State with a population of about 4.7 million [@bib21]. It provides tertiary, secondary and primary healthcare services to all the neighbouring States. The hospital serves as the teaching hospital of the Medical School of Obafemi Awolowo University Ile-Ife and has other six schools under its jurisdiction.

Transparency document. Supplementary material {#s0055}
=============================================

Supplementary material

Appendix A. Supplementary material {#s0065}
==================================

Table 1 Radiological parameters of chest radiography of each patient (See [Supplementary data](#s0065){ref-type="sec"}).
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[^1]: ESD = entrance surface dose; BD = breast dose; ICR = incidence cancer risks; FFD = focus film distance; FSD = focus skin distance; kVp = kilovoltage peak; mAs = current time product.

[^2]: ESD = entrance surface dose; BD = breast dose; ICR = incidence cancer risks; FFD = focus film distance; FSD = focus skin distance; kVp = kilovoltage peak; mAs = current time product.

[^3]: ESD = entrance surface dose; E = effective dose; BMD = bone marrow dose; BD = breast dose; LD = lung dose; ICR~BM~ = incidence cancer risks for bone marrow; ICR~B~ = incidence cancer risks for breast; ICR~L~ = incidence cancer risks for lung; ICR~s~ = incidence cancer risks for solid cancers.

[^4]: ICR~BM~ = incidence cancer risks for bone marrow; ICR~B~ = incidence cancer risks for breast; ICR~L~ = incidence cancer risks for lung; ICR~s~ = incidence cancer risks for solid cancers.
